Determining the protein drug release characteristics and cell adhesion to a PLLA or PLGA biodegradable polymer membrane

Journal of Biomedical Materials Research - Part A

Volumn 94, Issue 1, 2010, Pages 27-37

  Burns, Sarah A ^a   Hard, Robert ^a   Hicks Jr , Wesley L ^b   Bright, Frank V ^a   Cohan, David ^b   Sigurdson, Lynn ^b   Gardella Jr , Joseph A ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Aerosol OT; Biodegradable polymers; Drug release; KGF; ToF SIMS

Indexed keywords

AEROSOL-OT; BIOLOGICAL RESPONSE; CELL SEEDING; CONCENTRATION OF; CONTROLLED RELEASE; DEGRADATION TIME; DRUG RELEASE; EPITHELIAL GROWTH; IN-VITRO; KERATINOCYTE GROWTH FACTORS; PLLA; POLYMER FORMULATION; POLYMER MATRICES; POLYMER MEMBRANE; PROTEIN DRUG DELIVERY; PROTEIN DRUGS; RELEASE KINETICS; RELEASE RATE; SURFACTANT STABILIZERS; TIME OF FLIGHT SECONDARY ION MASS SPECTROMETRY; TOF SIMS;

ADHESION; ATMOSPHERIC AEROSOLS; CELL ADHESION; CONTROLLED DRUG DELIVERY; ESTERS; FUNCTIONAL POLYMERS; GROWTH KINETICS; PROTEINS; SECONDARY ION MASS SPECTROMETRY; SURFACE ACTIVE AGENTS;

BIODEGRADABLE POLYMERS;

DOCUSATE SODIUM; KERATINOCYTE GROWTH FACTOR; POLYGLACTIN; POLYLACTIC ACID;

ARTICLE; BIOCOMPATIBILITY; CELL ADHESION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ENCAPSULATION; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN CELL; TIME OF FLIGHT MASS SPECTROMETRY;

BIOCOMPATIBLE MATERIALS; CELL ADHESION; CELL LINE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FIBROBLAST GROWTH FACTOR 7; HUMANS; LACTIC ACID; MATERIALS TESTING; POLYGLYCOLIC ACID; POLYMERS;

EID: 77952724726     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32654     Document Type: Article

References (45)

1. Ishaug SL, Crane GM, Miller MJ, Yasko AW, Yaszemski MJ, Mikos AG. Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res 1997;38:17-28.
2. Kim BS, Mooney DJ. Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends Biotechnol 1998;16:224-230.
3. Hutmacher D. Scaffolds in tissue engineering bone and cartilage. Biomaterials 2000;21:2529-2543.
4. Liu XH, Ma PX. Polymeric scaffolds for bone tissue engineering. Ann Biomed Eng 2004;32:477-486.
5. Melo EP, Aires-Barros MR, Cabral JM. Reverse micelles and protein biotechnology. Biotechnol Annu Rev 2001;7:87-129.
6. Gombotz WR, Pettit DK. Biodegradable polymers for protein and peptide drug delivery. Bioconjug Chem 1995;6:332-351.
7. Cho EJ, Tao Z, Tang Y, Tehan EC, Bright FV, Hicks WL, Gardella JA, Hard R. Tailored delivery of active kerainocyte growth factor from biodegradable polymer formulations. J Biomed Mater Res 2003;66A:417-424. (Pubitemid 37517243)
8. Lee JW, Gardella JA. Simultaneous time-of-flight secondary ion MS quantitative analysis of drug surface concentration and polymer degradation kinetics in biodegradable poly (L-lactic acid) blends. Anal Chem 2003;75:2950-2958.
9. Ikada Y, Tsuji H. Biodegradable polyesters for medical and ecological applications. Macromol Rapid Commun 2000;21: 117-132.
10. Discher DE, Eisenbergy A. Polymer vesicles. Science 2002; 297:967-973.
11. Heller J, Barr J, Ng SY, Abdellauoi KS, Gurny R. Poly (ortho esters): Synthesis, characterization, properties and uses. Adv Drug Deliv Rev 2002;54:1015-1039.
12. Luisi PL, Giomini M, Pileni MP, Robinson BH. Reverse micelles as hosts for proteins and small molecules. Biochim Biophys Acta 1988;947:209-246. (Pubitemid 18062317)
13. Ono T, Goto M. Application of reversed micelles in bioengineering. Curr Opin Colloid Interface Sci 1997;2:397-401.
14. Werner S, Peters KG, Longaker MT, Fuller-Pace F, Banda MJ, Williams LT. Large induction of keratinocyte growth factor expresn in the dermis during wound healing. Proc Natl Acad Sci USA 1992;89:6869-6900.
15. Gibbs S, Pinto ANS, Murli S, Huber M, Hohl D, Ponec M. Epidermal growth factor and keratinocyte growth factor differentially regulate epidermal migration, growth, and differentiation. Wound Repair Regen 2000;8:192-203. (Pubitemid 30421522)
16. Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG, Werner S. Regulation of vascular endothelial growth-factor expression in cultured keratinocytes-implications for normal and impaired wound-healing. J Biol Chem 1995;270:12607-12613.
17. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988;106:761-771. (Pubitemid 18089976)
18. Travers JB, Harrison KA, Johnson CA, Clay KL, Morelli JG. Platelet-activating factor biosynthesis induced by various stimuli in human HaCaT keratinocytes. J Invest Dermatol 1996;107:88-94.
19. Maas-Szabowski N, Starker A, Fusenig N. Epidermal tissue regeneration and stromal interaction in HaCaT cells is initiated by TGF-a. J Cell Sci 2003;116:2937-2948. (Pubitemid 36926983)
20. Frank CW, Rao V, Despotopoulou MM, Pease RFW, Hinsberg WD, Miller RD, Rabolt JF. Structure in thin and ultrathin spin-cast polymer films. Science 1996;273:912-915. (Pubitemid 26275157)
21. Burns SA, Gardella JA. Quantitative ToF-SIMS studies of protein drug release from biodegradable polymer drug delivery membranes. Appl Surf Sci 2008;255:1170-1173.
22. Lu LC, Nyalakonda K, Kam L, Bizios R, Gopferich A, Mikos AG. Retinal pigment epithelial cell adhesion on novel micropatterned surfaces fabricated from synthetic biodegradable polymers. Biomaterials 2001;22:291-297.
23. Owen GR, Jackson J, Chehroudi B, Burt H, Brunette DM. A PLGA membrane controlling cell behaviour for promoting tissue regeneration. Biomaterials 2005;26:7447-7456. (Pubitemid 41133596)
24. Beckstead BL, Pan S, Bhrany AD, Bratt-Leal AM, Ratner BD, Giachelli CM. Esophageal epithelial cell interaction with synthetic and natural scaffolds for tissue engineering. Biomaterials 2005;26:6217-6228. (Pubitemid 40826990)
25. Martina M, Hutmacher DW. Biodegradable polymers applied in tissue engineering research: A review. Polym Int 2007;56: 145-157. (Pubitemid 46165222)
26. Gupta RR, Jain SK, Varshney M. AOT water-in-oil microemulsions as a penetration enhancer in transdermal drug delivery of 5-fluorouracil. Colloids Surf B Biointerfaces 2005; 41:25-32. (Pubitemid 40215481)
27. Changez M, Varshney M. Aerosol-OT microemulsions as trasdermal carriers of tetracaine hydrochloride. Drug Dev Ind Pharm 2000;26:507. (Pubitemid 30225628)
28. Miller M-C, Nanchahal J. Advances in the modulation of cutaneous wound healing and scarring. Biodrugs 2005;19: 363-381. (Pubitemid 43060720)
29. Singer AJ, Clark RAF. Cutaneous wound healing. N Engl J Med 1999;341:738-746.
30. Alexis F. Factors affecting the degradation and drug-release mechanism of poly(lactic acid) and poly[(lactic acid)-co- (glycolic acid)]. Polym Int 2005;54:36-46. (Pubitemid 40032749)
31. Uhrich KE, Cannizzaro SM, Langer RS, Shakesheff KM. Polymeric systems for controlled drug release. Chem Rev 1999;99: 3181-3198. (Pubitemid 129583051)
32. Huang Y-Y, Qi M, Liu H-Z, Zhao H, Yang D-Z. Degradation of porous poly (D,L-lactic-co-glycolic acid) films based on water diffusion. J Biomed Mater Res 2007;80A:909-915. (Pubitemid 46309994)
33. Tsuji H, Ikada Y. Properties and morphology of Poly(L-lactide). II. Hydrolysis in alkaline solution. J Polym Sci Part A: Polym Chem 1998;36:59-66. (Pubitemid 128576990)
34. Gombotz WR, Pettit DK. Biodegradable polymers for protein and peptide drug delivery. Bioconjug Chem 1995;6:332-351.
35. Park TG, Cohen S, Langer RS. Poly (L-lactic acid)/pluronic blends: Characterization of phase separation behavior, degradation, and morphology and use as protein-releasing matrices. Macromolecules 1992;25:116-122.
36. Omelczuk MO, McGinity JW. The influence of polymer glass transition temperature and moleculer weight on drug release from tablets containing poly (DL-lactic acid). Pharm Res 1992; 9:26-32.
37. Rapra Technology Limited. Handbook of Biodegradable Polymers. Shawbury, United Kingdom: Rapra Technology Limited; 2005.
38. Gopferich A. Mechanisms of polymer degradation and erosion. Biomaterials 1996;17:103-114.
39. Park TG. Degradation of poly(lactic-co-glycolic acid) microspheres: Effect of copolymer composition. Biomaterials 1995; 16:1123-1130.
40. Park TG. Bioconjugation of biodegradable poly(lactic/glycolic acid) to protein, peptide and anti-cancer drug: An alternative pathway for achieving controlled release from micro- and nanoparticles. In: Ottenbrite RM, Kim SW, editors. Polymeric Drugs & Drug Delivery Systems. Boca Raton, FL: CRC Press LLC; 2001. p 101-114.
41. Mohamed F, van der Walle Christopher F. Engineering biodegradable polyester particles with specific drug targeting and drug release properties. J Pharm Sci 2008;97:71-87.
42. Willis L, Nair B. Amended final report on the safety assessment of dioctyl sodium sulfosuccinate. Int J Toxicol 1998;17 (Suppl. 4):1-20. (Pubitemid 28500629)
43. Mahoney CM, Robertson S, Gillen G. Dynamic SIMS utilizing SF5+ polyatomic primary ion beams for drug delivery applications. Appl Surf Sci 2004;231/232:174-178.
44. Mahoney CM, Yu J, Fahey A, Gardella JAJ. SIMS depth profiling of polymer blends with protein based drugs. Appl Surf Sci 2006;252:6609-6614. (Pubitemid 44233756)
45. Mahoney CM, Yu J, Gardella JAJ. Depth profiling of poly(L-lactic acid)/triblock copolymer blends with time-of- flight secondary ion mass spectrometry. Anal Chem 2005; 77:3570-3578. (Pubitemid 40799848)